Product Categories
| Country: | United States |
|---|---|
| Tel: | 781-+1-781-999-5354 |
| Mobile: | +1-00000000000 |
| E-mail: | info@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36 Washington Street, Wellesley Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| A331440；A331440 free base;A 331440;A-331440 | C22H27N3O | 392338-13-5 | Details |
| Tazofelone；LY-213829 | C18H27NO2S | 107902-67-0 | Details |
| Alteminostat | C27H36N6O3 | 1246374-97-9 | Details |
| SCH-486757；SCH 486757;SCH486757 | C24H23Cl2N3O | 524019-25-8 | Details |
| SB 258719 hydrochloride | C18H31ClN2O2S | 1217674-10-6 | Details |
| MRT-68601 HCl；MRT 68601 HCl;MRT68601 HCl | C25H34N6O2 | 1190379-37-3 | Details |
| Abediterol napadisylate；LAS100977 napadisylate | C35H38F2N2O10S2 | 1044516-17-7 | Details |
| Pralatrexate, (S)- | C23H23N7O5 | 1320211-69-5 | Details |
| JNJ28871063 hydrochloride；JNJ 28871063 hydrochloride | C24H28Cl2N6O3 | 944342-90-9 | Details |
| ChX710 | C18H21N5O | 2438721-44-7 | Details |
| K67；K 67;K-67 | C29H30N2O7S2 | 2046250-48-8 | Details |
| Myrtenal；NSC54384;NSC-54384;Benihinal;NSC 54384 | C10H14O | 564-94-3 | Details |
| C188；STAT3-IN-C188;C 188;Cpd-188;C-188;Cpd188 | C19H15NO7S2 | 823828-18-8 | Details |
| PF-06372222；PF 0637222;PF0637222;PF-0637222 | C26H28F3N5O3 | 1407592-99-7 | Details |
| E7107；E-7107;E 7107 | C40H66N2O9 | 630100-90-2 | Details |
| ND-378 | C18H19NO4S2 | 1807453-72-0 | Details |
| CPP-115；CPP115;CPP 115 | C7H9F2NO2 | 640897-20-7 | Details |
| TC-S 7005 | C21H17N3O3 | 1082739-92-1 | Details |
| 7H-Benzimidazo(2,1-a)benz(de)isoquinolin-7-one | C18H10N2O | 23749-58-8 | Details |
| Irbesartan HCl；BMS 186295;BMS186295;Irbesartan hydrochloride;BMS-186295 | C25H29ClN6O | 329055-23-4 | Details |
| Benzil；NSC 220315;NSC-220315;NSC220315 | C14H10O2 | 134-81-6 | Details |
| Cipralisant maleate；GT2331;Cipralisant maleate. trade name Perceptin;GT-2331;GT 2331 | C18H24N2O4 | 223420-20-0 | Details |
| Dasolampanel etibutil | C23H32ClN5O3 | 503291-52-9 | Details |
| Irganox 1010；Dovernox 10 | C73H108O12 | 6683-19-8 | Details |
| NF-1819；NF1819;NF 1819 | C24H22FN5O4 | 1881244-28-5 | Details |
| TC-G 1000 | C17H18N2O4S | 245744-18-7 | Details |
| L-838417；L838417;L 838417 | C19H19F2N7O | 286456-42-6 | Details |
| Losartan potassium impurity E；L-158507;L158507;L 158507 | C14H12N4 | 120568-11-8 | Details |
| WJ460 | C27H28N2O3S | 1415251-36-3 | Details |
| BIBO3304；BIBO-3304;BIBO 3304 | C29H35N7O3 | 191868-13-0 | Details |
| BzDANP；Benzo DANP;BenzoDANP;Benzo-DANP | C18H24N6 | 1994258-88-6 | Details |
| Dezapelisib；INCB040093;INCB-040093;INCB 040093 | C20H16FN7OS | 1262440-25-4 | Details |
| Benzyldodecyldimethylammonium Chloride Dihydrate | C21H42ClNO2 | 147228-80-6 | Details |
| PYR-9588；PYR9588;PYR 9588 | C7H9NO | 2199-58-8 | Details |
| TG53；TG 53;TG-53 | C21H22ClN5O2 | 946369-04-6 | Details |
| LDV FITC | C69H81N11O17S | 1207610-07-8 | Details |
| Diphenidol；Difenidol;SKF 478;Difenidolo;SKF-478;SKF478 | C21H27NO | 972-02-1 | Details |
| Histrelin；Supprelin LA;Histrelin Acetate | C66H86N18O12 | 76712-82-8 | Details |
| DMAB-anabaseine dihydrochloride；N,N-dimethyl-4-[(E)-(6-pyridin-3-yl-3,4-dihydro-2H-pyridin-5-ylidene)methyl]aniline;dihydrochloride | C19H22ClN3 | 154149-38-9 | Details |
| Alflutinib；AST2818;ASK120067 | C28H31F3N8O2 | 1869057-83-9 | Details |
| Reltecimod sodium；AB 103 sodium;AB-103 sodium;AB103 sodium | C46H73N10NaO15S | 1943755-99-4 | Details |
| Cystamine dihydrochloride | C4H14Cl2N2S2 | 56-17-7 | Details |
| HM-50316；HM 50316;HM50316 | C29H23ClN2O3S | 1310361-52-4 | Details |
| rac-CCT-250863 | C24H25F3N4O2S | 1364269-06-6 | Details |
| OBI-3424 | C21H25N4O6P | 2097713-68-1 | Details |
| JNJ-10311795；JNJ10311795;JNJ 10311795 | C40H35N2O6P | 518062-14-1 | Details |
| UBP-282；UBP 282 | C15H15N3O6 | 544697-47-4 | Details |
| WST-1；WST 1;WST1 | C19H11IN5NaO8S2 | 150849-52-8 | Details |
| 1,2-Dilauroyl-sn-glycerol；(S)-1,2-Dilaurin;1,2-DLG | C27H52O5 | 60562-15-4 | Details |
| Butaprost；TR-4979;(R)-Butaprost;Butaprostum | C24H40O5 | 69648-38-0 | Details |
| FAUC 213；FAUC-213;FAUC213 | C18H19ClN4 | 337972-47-1 | Details |
| LY 53857；LY-53857;LY53857 | C27H36N2O7 | 60634-51-7 | Details |
| TMPH hydrochloride | C16H32ClNO2 | 849461-91-2 | Details |
| Diisooctyl sebacate；diisooctyl ester;Decanedioic acid | C26H50O4 | 27214-90-0 | Details |
| Gatifloxacin mesylate | C19H22FN3O4.CH4O3S | 316819-28-0 | Details |
| 6bK；6 bK;IDE-IN-6bK;IDE-inhibitor-6bK;6-bK;IDE inhibitor 6bK | C43H56F3N7O9 | 1774353-12-6 | Details |
| BCTP | C17H16ClN3OS | 464152-46-3 | Details |
| Neladenoson dalanate HCl；Neladenoson dalanate hydrochloride | C35H35Cl2N7O4S2 | 1239235-25-6 | Details |
| BRD0476；BRD-0476;BRD 0476;ML 187;ML-187;ML187 | C35H38N4O8S | 1314958-91-2 | Details |
| SA-16；SA 16;SA16 | C33H24F2N6O4 | 1919884-11-9 | Details |
| IMTPPE；SID3712502;SID-3712502;SID 3712502 | C20H27N3O2S | 851688-13-6 | Details |
| LBT 999；LBT999;LBT-999 | C20H26FNO2 | 877467-20-4 | Details |
| AA-CW236；AACW 236;AACW236;AA-CW 236;AACW-236;AA-CW-236 | C17H16ClF3N4O2 | 1869921-96-9 | Details |
| BMS-242；BMS242 | C28H35NO4 | 1675204-51-9 | Details |
| EPZ-030456；EPZ 030456;EPZ030456 | C28H34ClN5O4S | 1808011-23-5 | Details |
| EZH2-IN-3；EZH2-inhibitor-3;EZH2 inhibitor 3;EZH2IN3;EZH2 IN 3 | C27H28ClN5O2 | 1377997-28-8 | Details |
| GAT211；GAT 211;AZ4;AZ-4;GAT-211;AZ 4 | C22H18N2O2 | 102704-40-5 | Details |
| ML404；ML-404;ML 404 | C17H13ClN2O3 | 1826026-00-9 | Details |
| Olacaftor；VX-440;VX 440;VX440 | C29H34FN3O4S | 1897384-89-2 | Details |
| RO2468；RO-2468;RO 2468 | C30H30Cl2FN5O4 | 1360821-21-1 | Details |
| TNKS-IN-41；TNKS inhibitor 41;TNKS IN 41;TNKS inhibitor-41;TNKSIN41 | C24H22N10O2 | 1584646-59-2 | Details |
| N-tert-butyl-α-Phenylnitrone；(Z)-N-benzylidene-2-Methylpropan-2-aMine oxide | C11H15NO | 3376-24-7 | Details |
| Bicine；Diethanol glycine;Diethylolglycine;N,N-Bis(2-hydroxyethyl)glycine;Dihydroxyethylglycine | C6H13NO4 | 150-25-4 | Details |
| GSK649A | C15H12ClFN6OS | 1848232-20-1 | Details |
| NSC49652；NSC-49652;NSC 49652 | C14H11NO2 | 908563-68-8 | Details |
| N-Methylphthalimide；NSC-44059;NSC44059;NSC 44059 | C9H7NO2 | 550-44-7 | Details |
| GSK 1562590 hydrochloride | C30H31Cl3N4O4 | 1003878-07-6 | Details |
| 2-Methylthio-ATP tetrasodium；2-Methylthioadenosine triphosphate tetrasodium salt;2-methylthio-atp-tetrasodium | C11H19N5NaO13P3S | 100020-57-3 | Details |
| RuBi-4AP | C30H28ClN8Ru+ | 851956-02-0 | Details |
| Pirimicarb | C11H18N4O2 | 23103-98-2 | Details |
| ACPT-II | C8H11NO6 | 195209-04-2 | Details |
| Mosapramine；Y516;Y-516;Clospipramine;Cremin;Y 516 | C28H35ClN4O | 89419-40-9 | Details |
| Telratolimod；MEDI9197;3M-052 | C36H59N5O2 | 1359993-59-1 | Details |
| Asalhydromorphone | C35H31NO9 | 1431529-94-0 | Details |
| Rabacfosadine succinate；VDC-1101 succinate;GS-9219 succinate;GS-9219-01;VDC 1101 succinate VDC1101 succinate | C25H41N8O10P | 1431856-99-3 | Details |
| Roseoflavin | C18H23N5O6 | 51093-55-1 | Details |
| Cyheptamide；AY 8682;AY-8682 | C16H15NO | 7199-29-3 | Details |
| CHMFL-FLT3-122；CHMFLFLT3122;CHMFL FLT3 122 | C26H29N7O2 | 1839150-56-9 | Details |
| L-796568 free base；L 796568 free base;L796568 free base | C31H27F3N4O3S2 | 211031-01-5 | Details |
| Quinpirole dihydrochloride；(±)Quinpirole dihydrochloride;LY 141865;(±)-Quinpirole dihydrochloride;Quinpirole 2HCl;LY-141865 | C13H22ClN3 | 73625-62-4 | Details |
| NH2-PEG3-C2-Boc；Amino-PEG3-t-butyl ester | C13H27NO5 | 252881-74-6 | Details |
| Cellufluor；Tinopal 5BMS;Kayaphor FB;Phorwite AR;Paper White BP | C40H45N12NaO10S2 | 4193-55-9 | Details |
| sPLA2 inhibitor 1；KH064;KH-064;5-BPP acid;KH 064 | C31H37NO4 | 393569-31-8 | Details |
| Hydrastinine hydrochloride | C11H13NO3.ClH | 4884-68-8 | Details |
| SL 0101-1；SL0101 | C25H24O12 | 77307-50-7 | Details |
| C.I. Vat Brown 3 | C42H23N3O6 | 131-92-0 | Details |
| MMPP | C17H18O3 | 1895957-18-2 | Details |
| RL648_81 | C17H17F4N3O2 | 1919050-87-5 | Details |
| YKL-5-124 | C28H33N7O3 | 1957203-01-8 | Details |
| IDT | C8H5NS2 | 18138-19-7 | Details |
| Product Total： Product Page： | ||||
| 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 | ||||